Build with KISHO Sign In Sign Up

Kisho

Cadila Healthcare Limited, India — Rare Disease Pipeline | Kisho | Kisho

Cadila Healthcare Limited, India

Other

1

Orphan Designations

0

FDA Approvals

3

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
post-thrombotic syndrome	Murine IgG1 monoclonal antibody binding to site II on G protein of rabies virus envelope and murine IgG2b monoclonal antibody binding to site III on G protein of rabies virus envelope	Orphan Designation	-
post-traumatic stress disorder	Murine IgG1 monoclonal antibody binding to site II on G protein of rabies virus envelope and murine IgG2b monoclonal antibody binding to site III on G protein of rabies virus envelope	Orphan Designation	-
post-vaccinal encephalitis	Murine IgG1 monoclonal antibody binding to site II on G protein of rabies virus envelope and murine IgG2b monoclonal antibody binding to site III on G protein of rabies virus envelope	Orphan Designation	-

← Back to Companies